Linde plc (EU)

  • WKN: A2DSYC
  • ISIN: IE00BZ12WP82
  • Land: Irland

Nachricht vom 21.06.2021 | 16:43

DGAP-DD: Linde plc english


Linde plc: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
21.06.2021 / 16:43
The issuer is solely responsible for the content of this announcement.

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Prof. Dr. Ann-Kristin Achleitner
2 Reason for the notification
a) Position/status Director
b) Initial Notification Amendment Initial notification
 
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Linde public limited company
b) LEI 8945002PAZHZLBGKGF02
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument,
type of
instrument
Identification code
Restricted Stock Units ('RSUs')

International Securities Identification Number (ISIN): IE00BZ12WP82

German Securities Identification Number (Wertpapierkennnummer, WKN): A2D SYC

Ticker Symbol: LIN
b) Nature of the transaction Acquisition of RSUs
The acquisition of 1.893 RSUs of Linde plc as a result of automatic dividend reinvestment pursuant to an outstanding RSU grant.
c) Price(s) and volume(s) Price(s) Volume(s)
    Acquisition of RSUs
    US$0.00 1.893
d) Aggregated information Price Aggregated volume
    N/A N/A
e) Dates of the transactions 17 JUNE 2021
f) Place of the transaction Outside of trading venue
g) Additional Information The 1.893 RSUs will payout in Linde plc ordinary shares on a one-for-one basis in accordance with the RSU grant agreement.


21.06.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

Aktuelle Research-Studie

Original-Research: Gold Mountain Mining Corp. (von hanseatic stock publishing UG (haftungsbeschränkt)): Gold Mountain Mining Corp.

29. November 2021